Literature DB >> 24048355

Shaping the interaction landscape of bioactive molecules.

David Gfeller1, Olivier Michielin, Vincent Zoete.   

Abstract

MOTIVATION: Most bioactive molecules perform their action by interacting with proteins or other macromolecules. However, for a significant fraction of them, the primary target remains unknown. In addition, the majority of bioactive molecules have more than one target, many of which are poorly characterized. Computational predictions of bioactive molecule targets based on similarity with known ligands are powerful to narrow down the number of potential targets and to rationalize side effects of known molecules.
RESULTS: Using a reference set of 224 412 molecules active on 1700 human proteins, we show that accurate target prediction can be achieved by combining different measures of chemical similarity based on both chemical structure and molecular shape. Our results indicate that the combined approach is especially efficient when no ligand with the same scaffold or from the same chemical series has yet been discovered. We also observe that different combinations of similarity measures are optimal for different molecular properties, such as the number of heavy atoms. This further highlights the importance of considering different classes of similarity measures between new molecules and known ligands to accurately predict their targets.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24048355     DOI: 10.1093/bioinformatics/btt540

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  92 in total

1.  Validation strategies for target prediction methods.

Authors:  Neann Mathai; Ya Chen; Johannes Kirchmair
Journal:  Brief Bioinform       Date:  2020-05-21       Impact factor: 11.622

2.  Comparative transcriptomics and network pharmacology analysis to identify the potential mechanism of celastrol against osteoarthritis.

Authors:  Siming Dai; Hui Wang; Meng Wang; Yue Zhang; Zhiyi Zhang; Zhiguo Lin
Journal:  Clin Rheumatol       Date:  2021-04-19       Impact factor: 2.980

3.  Computational approaches to find the active binding sites of biological targets against busulfan.

Authors:  T Karthick; Poonam Tandon
Journal:  J Mol Model       Date:  2016-05-30       Impact factor: 1.810

4.  Xeronine structure and function: computational comparative mastery of its mystery.

Authors:  David Morakinyo Sanni; Toluwase Hezekiah Fatoki; Ayodele Oluseyi Kolawole; Afolabi Clement Akinmoladun
Journal:  In Silico Pharmacol       Date:  2017-09-02

5.  SwissTargetPrediction: a web server for target prediction of bioactive small molecules.

Authors:  David Gfeller; Aurélien Grosdidier; Matthias Wirth; Antoine Daina; Olivier Michielin; Vincent Zoete
Journal:  Nucleic Acids Res       Date:  2014-05-03       Impact factor: 16.971

6.  Focused Screening Identifies Evoxine as a Small Molecule That Counteracts CO2-Induced Immune Suppression.

Authors:  Iiro Taneli Helenius; Aisha Nair; Humberto E Trejo Bittar; Jacob I Sznajder; Peter H S Sporn; Greg J Beitel
Journal:  J Biomol Screen       Date:  2015-12-23

7.  Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights.

Authors:  Ahmed Sabt; Wagdy M Eldehna; Tarfah Al-Warhi; Ohoud J Alotaibi; Mahmoud M Elaasser; Howayda Suliman; Hatem A Abdel-Aziz
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

8.  A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers.

Authors:  Bashir Lawal; Wen-Cheng Lo; Ntlotlang Mokgautsi; Maryam Rachmawati Sumitra; Harshita Khedkar; Alexander Th Wu; Hsu-Shan Huang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

9.  Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics.

Authors:  Riley D Kirk; Kassie Picard; Joseph A Christian; Shelby L Johnson; Brenton DeBoef; Matthew J Bertin
Journal:  ACS Chem Neurosci       Date:  2020-12-07       Impact factor: 4.418

10.  Insights on a new sulfonamide chalcone with potential antineoplastic application.

Authors:  Patricia R S Wenceslau; Renata L G de Paula; Vitor S Duarte; Giulio D C D'Oliveira; Laura M M Guimarães; Caridad N Pérez; Leonardo L Borges; José L R Martins; James O Fajemiroye; Chris H J Franco; Pal Perjesi; Hamilton B Napolitano
Journal:  J Mol Model       Date:  2021-06-26       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.